Turunen, Nina <br/><br/>
Thioredoxin is associated with proliferation, p53 expression and negative estrogen and progesterone receptor status in breast carcinoma.  [electronic resource] 

 -  APMIS : acta pathologica, microbiologica, et immunologica Scandinavica  Feb 2004 
 - 123-32 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0903-4641 
<br/><br/><label>Standard No.: </label>10.1111/j.1600-0463.2004.apm1120207.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Breast Neoplasms--enzymology<br/>Carcinoma in Situ--enzymology<br/>Carcinoma, Ductal--enzymology<br/>Carcinoma, Lobular--enzymology<br/>Female<br/>Humans<br/>Immunohistochemistry<br/>NF-kappa B--metabolism<br/>Neoplasm Recurrence, Local--pathology<br/>Proliferating Cell Nuclear Antigen--metabolism<br/>Receptors, Estrogen--metabolism<br/>Receptors, Progesterone--metabolism<br/>Survival Analysis<br/>Thioredoxin-Disulfide Reductase--biosynthesis<br/>Thioredoxins--biosynthesis<br/>Tumor Suppressor Protein p53--metabolism